With countries around the world drafting their exit strategies in preparation for life after COVID-19 lockdown, all eyes are on the market. Promising data from the trial evaluating Gilead’s (NASDAQ:GILD) COVID-19 treatment and the U.S. government’s stimulus measures indicate the storm brewing over Wall Street might be clearing. Investors wonder which stocks to buy will be survivors.
While these developments are encouraging, U.S. crude futures turned negative for the first time in history on April 20 as lockdowns erase oil demand. This reflects the extent of COVID-19’s damage to the economy. As a result, market watchers are looking to the insiders, hoping insights from their activity can steer